These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 10837025)

  • 1. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
    Kolligs FT; Hu G; Dang CV; Fearon ER
    Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
    Williams BO; Barish GD; Klymkowsky MW; Varmus HE
    Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catenins, Wnt signaling and cancer.
    Barker N; Clevers H
    Bioessays; 2000 Nov; 22(11):961-5. PubMed ID: 11056471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
    Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
    J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
    Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
    Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
    Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
    Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Carcinogenesis; 1999 Apr; 20(4):737-40. PubMed ID: 10223208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
    Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.